ProShares UltraShort Health Care
RXD
4 hedge funds and large institutions have $1.18M invested in ProShares UltraShort Health Care in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
438% more capital inflows, than outflows
Capital inflows: $627K | Capital outflows: $116K
33% more funds holding
Funds holding: 3 → 4 (+1)
24% more call options, than puts
Call options by funds: $80.5M | Put options by funds: $64.9M
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
United Capital Financial Advisors
Irving,
Texas
|
+$390K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$237K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS
Zurich,
Switzerland
|
-$116K |
RXD Hedge Fund Activity: Q3 2014 in Review
4 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q3 2014, worth a combined $1.18M — up 47% from $805K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new RXD positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was United Capital Financial Advisors, opening a new position worth an estimated $390K. The largest seller was UBS, cutting an estimated $116K.
- 4 institutional investors held ProShares UltraShort Health Care (RXD) as of Q3 2014, up from 3 in Q2 2014.
- Funds reported $1.18M of ProShares UltraShort Health Care stock for Q3 2014, up 47% quarter-over-quarter.
- 1 fund opened new ProShares UltraShort Health Care positions in Q3 2014 and 0 closed out, a net change of +1 holder.
- The largest ProShares UltraShort Health Care buyer in Q3 2014 was United Capital Financial Advisors, an estimated $390K added.
- The largest ProShares UltraShort Health Care seller in Q3 2014 was UBS, an estimated $116K sold.
Based on aggregated 13F filings for Q3 2014.